JP2010526090A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010526090A5 JP2010526090A5 JP2010506618A JP2010506618A JP2010526090A5 JP 2010526090 A5 JP2010526090 A5 JP 2010526090A5 JP 2010506618 A JP2010506618 A JP 2010506618A JP 2010506618 A JP2010506618 A JP 2010506618A JP 2010526090 A5 JP2010526090 A5 JP 2010526090A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- oligopeptide
- sequence
- polypeptide
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US91490207P | 2007-04-30 | 2007-04-30 | |
| PCT/US2008/062092 WO2008134752A2 (en) | 2007-04-30 | 2008-04-30 | Methods and compositions for the treatment of cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010526090A JP2010526090A (ja) | 2010-07-29 |
| JP2010526090A5 true JP2010526090A5 (enExample) | 2011-01-06 |
Family
ID=39926323
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010506618A Pending JP2010526090A (ja) | 2007-04-30 | 2008-04-30 | 癌の治療のための方法および組成物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US8198236B2 (enExample) |
| EP (1) | EP2150270A4 (enExample) |
| JP (1) | JP2010526090A (enExample) |
| AU (1) | AU2008245425A1 (enExample) |
| BR (1) | BRPI0810207A2 (enExample) |
| CA (1) | CA2685737A1 (enExample) |
| WO (1) | WO2008134752A2 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080227698A1 (en) * | 2005-11-08 | 2008-09-18 | Washington University | Oligopeptides for treatment of osteoporosis and other bone diseases and methods thereof |
| EP2427490A1 (en) * | 2009-05-07 | 2012-03-14 | Novartis AG | Compositions and methods of use for binding molecules to dickkopf-1 or dickkopf-4 or both |
| CA2798432A1 (en) * | 2010-05-06 | 2011-11-10 | Novartis Ag | Compositions and methods of use for therapeutic low density lipoprotein -related protein 6 (lrp6) antibodies |
| KR20140091031A (ko) | 2011-11-04 | 2014-07-18 | 노파르티스 아게 | 저밀도 지단백질-관련 단백질 6 (lrp6) - 반감기 연장제 구축물 |
| WO2014109519A1 (ko) * | 2013-01-10 | 2014-07-17 | 강원대학교산학협력단 | 작은안구증-연관 전사인자 유래의 펩타이드 및 이를 포함하는 조성물 |
| EP3265112B1 (en) * | 2015-01-19 | 2025-12-24 | Technion Research & Development Foundation Limited | Ubiquitin ligase kpc1 and p50 for use in the treatment of cancer |
| KR102073144B1 (ko) * | 2018-12-13 | 2020-02-04 | 주식회사 엘베이스 | 올리고펩티드를 유효성분으로 포함하는 암의 예방 또는 치료용 약학적 조성물 |
| CN114853847B (zh) | 2022-06-29 | 2022-09-27 | 中国农业大学 | 辣椒籽分离的寡肽ftle及其在预防或治疗癌症中的应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030104538A1 (en) * | 1997-09-18 | 2003-06-05 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| AU1918601A (en) * | 1999-11-19 | 2001-05-30 | Human Genome Sciences, Inc. | 23 human secreted proteins |
| US8637506B2 (en) * | 2003-09-22 | 2014-01-28 | Enzo Biochem, Inc. | Compositions and methods for bone formation and remodeling |
| US9062126B2 (en) | 2005-09-16 | 2015-06-23 | Raptor Pharmaceuticals Inc. | Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof |
| US20080227698A1 (en) * | 2005-11-08 | 2008-09-18 | Washington University | Oligopeptides for treatment of osteoporosis and other bone diseases and methods thereof |
-
2008
- 2008-04-30 EP EP08747240A patent/EP2150270A4/en not_active Withdrawn
- 2008-04-30 WO PCT/US2008/062092 patent/WO2008134752A2/en not_active Ceased
- 2008-04-30 US US12/598,240 patent/US8198236B2/en not_active Expired - Fee Related
- 2008-04-30 JP JP2010506618A patent/JP2010526090A/ja active Pending
- 2008-04-30 BR BRPI0810207-4A2A patent/BRPI0810207A2/pt not_active IP Right Cessation
- 2008-04-30 AU AU2008245425A patent/AU2008245425A1/en not_active Abandoned
- 2008-04-30 CA CA002685737A patent/CA2685737A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010534684A5 (enExample) | ||
| RU2016146198A (ru) | Терапевтические dll4-связывающие белки | |
| JP2015134796A5 (enExample) | ||
| JP2013539454A5 (enExample) | ||
| JP2018029595A5 (enExample) | ||
| JP2017006120A5 (enExample) | ||
| RU2015119517A (ru) | Новый способ лечения инфаркта миокарда с применением фрагмента hmgb1 | |
| JP2011511933A5 (enExample) | ||
| JP2012513418A5 (enExample) | ||
| EA201590986A1 (ru) | Антитела к ceacam5 и их применения | |
| CN101687022A8 (zh) | Prame衍生的肽以及包括该肽的免疫原组合物 | |
| JP2013530689A5 (enExample) | ||
| JP2012529293A5 (enExample) | ||
| MX360208B (es) | Composicion farmaceutica para el tratamiento y/o prevencion del cancer. | |
| JP2011520451A5 (enExample) | ||
| JP2016527891A5 (enExample) | ||
| WO2016004906A3 (zh) | 一种肿瘤血管阻断剂多肽、基因、表达载体及其应用 | |
| RU2019119609A (ru) | Пептиды, способные реактивировать мутанты р53 | |
| UA100127C2 (ru) | Пептид cdh3 и лекарственное средство, содержащее его | |
| JP2007526248A5 (enExample) | ||
| EP3275507A3 (en) | Vaccine delivery method | |
| IL195831A0 (en) | Sparc-derived tumor rejection antigenic peptides and medicaments comprising the same | |
| WO2011029008A3 (en) | Synbodies to akt1 | |
| JP2011505414A5 (enExample) | ||
| CN110382500A (zh) | 用于ido和tdo双重抑制剂的脲类化合物 |